Ingenuity’s software tools are expected to add functionality to Sage’s disease networks and algorithms.

Ingenuity Systems has given Sage Bionetworks the right to utilize its analysis software, IPA®, and the Ingenuity Knowledge Base of structured biomedical findings to inform and enhance Sage’s predictive disease models.

Sage’s web portal will also provide links to the Ingenuity Knowledge Base and IPA. The company’s content, algorithms, and predictive disease networks will also be made available within Ingenuity products like IPA.

Researchers will thus be able to use the content and algorithms from Sage within IPA to analyze molecular data, generate testable hypotheses, and build and visualize predictive disease models. “Leveraging their high-quality, expert-reviewed Ingenuity Knowledge Base Findings and their powerful pathway analytics in our research will enhance and add functionality to our predictive disease networks and algorithms,” says Stephen Friend, president, Sage Bionetworks.

The IPA software helps researchers model, analyze, and understand the complex biological and chemical systems at the core of life science research. It integrates data from a variety of experimental platforms and provides insight into the molecular and chemical interactions, cellular phenotypes, and disease processes of a system.

Previous articlePfizer Taps Academia with Launch of Global Centers for Therapeutic Innovation
Next articleCanterbury Health Laboratories to Leverage NimbleGen Microarray Cytogenetics Solution